AAAAAA
Results:
1-18
|
Results: 18
Authors:
DURELLI L
BONGIOANNI MR
FERRERO B
OGGERO A
MARZANO A
RIZZETTO M
Citation: L. Durelli et al., INTERFERON TREATMENT FOR MULTIPLE-SCLEROSIS - AUTOIMMUNE COMPLICATIONS MAY BE LETHAL, Neurology, 50(2), 1998, pp. 570-571
Authors:
FERRERO B
BONGIOANNI MR
MOIA MC
OGGERO A
GEUNA M
PAGNI R
DURELLI L
Citation: B. Ferrero et al., CORTICOSTEROID-INDUCED WORSENING OF MYASTHENIA-GRAVIS (MG) CORRELATESWITH INCREASED IN-VIVO ANTIACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY (AB) LEVEL AND IN-VITRO IMMUNOGLOBULIN (IG) G-RELEASE, Neurology, 48(3), 1997, pp. 1006-1006
Authors:
FERRERO B
AIMO G
PAGNI R
BERGAMASCO B
BONGIOANNI MR
BERGAMINI L
DURELLI L
Citation: B. Ferrero et al., MODIFIED AND IMPROVED ANTIACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY-ASSAY - COMPARISON OF ANALYTICAL AND CLINICAL-PERFORMANCE WITH CONVENTIONAL ANTI-ACHR ANTIBODY-ASSAY, Clinical chemistry, 43(5), 1997, pp. 824-831
Authors:
DURELLI L
BONGIOANNI MR
FERRERO B
FERRI R
IMPERIALE D
BRADAC GB
BERGUI M
GEUNA M
BERGAMINI L
BERGAMASCO B
Citation: L. Durelli et al., INTERFERON ALPHA-2A TREATMENT OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS - DISEASE-ACTIVITY RESUMES AFTER STOPPING TREATMENT, Neurology, 47(1), 1996, pp. 123-129
Authors:
BONGIOANNI MR
DURELLI L
FERRERO B
IMPERIALE D
OGGERO A
VERDUN E
AIMO G
PAGNI R
GEUNA M
BERGAMASCO B
Citation: Mr. Bongioanni et al., SYSTEMIC HIGH-DOSE RECOMBINANT-ALPHA-2A-INTERFERON THERAPY MODULATES LYMPHOKINE PRODUCTION IN MULTIPLE-SCLEROSIS, Journal of the neurological sciences, 143(1-2), 1996, pp. 91-99
Authors:
FERRERO B
GEBBIA V
CANNATA G
GIUFFRE S
VALENZA R
TESTA A
TIRRITO M
GEBBIA N
Citation: B. Ferrero et al., CISPLATIN PLUS VP16 AS SALVAGE TREATMENT FOR ADVANCED BREAST-CARCINOMA RESISTANT OR RECURRENT AFTER 1ST LINE CHEMOTHERAPY FOR METASTATIC DISEASE, Oncology Reports, 2(2), 1995, pp. 299-302
Authors:
GEBBIA V
MANTOVANI G
AGOSTARA B
CONTU A
FARRIS A
COLUCCI G
COGNETTI F
RESTIVO G
SPECIALE R
FERRERO B
TESTA A
CURRELI L
CARDINALE A
BAJETTA E
GEBBIA N
Citation: V. Gebbia et al., TREATMENT OF RECURRENT AND OR METASTATIC SQUAMOUS-CELL HEAD AND NECK-CARCINOMA WITH A COMBINATION OF VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL - A MULTICENTER PHASE-II TRIAL/, Annals of oncology, 6(10), 1995, pp. 987-991
Authors:
SCARZELLA L
DELSEDIME M
FERRERO B
GIANGRANDI C
PRIANO L
RIZZONE M
BERGAMASCO B
Citation: L. Scarzella et al., APOMORPHINE SC TREATMENT IN PARKINSONIAN-PATIENTS WITH LONG-TERM L-DOPA SYNDROME DURING L-DOPA DRUG HOLIDAY, Journal of neural transmission. Supplementum, (45), 1995, pp. 163-170
Authors:
DURELLI L
BONGIOANNI MR
FERRERO B
VERDUN E
RIVA A
GUENA M
BRADAC GB
BERGAMASCO B
BERGAMINI L
Citation: L. Durelli et al., CHRONIC ALFA INTERFERON (IFNA) TREATMENT FOR MULTIPLE-SCLEROSIS (MS) MODULATES CYTOKINE PRODUCTION RATHER THAN ANTIGEN PRESENTATION PROCESS, Neurology, 45(4), 1995, pp. 234-234
Authors:
FERRERO B
DURELLI L
BONGIOANNI MR
AIMO G
VERDUN E
BERGAMASCO B
Citation: B. Ferrero et al., DECREASED ANTIACETYLCHOLINE RECEPTOR ANTIBODY (ACHR AB) BINDING AVIDITY AFTER HIGH-DOSE GAMMA-GLOBULIN (HIG) CORRELATES WITH CLINICAL EFFICACY IN MYASTHENIA-GRAVIS (MG), Neurology, 45(4), 1995, pp. 283-284
Authors:
FERRERO B
AIMO G
DURELLI L
CAVALLO R
FERRI R
BONGIOANNI MR
BERGAMASCO B
Citation: B. Ferrero et al., HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN (IVIG) PREVENTS CORTICOSTEROID (ST)-INDUCED WORSENING OF MYASTHENIA-GRAVIS (MG), Neurology, 44(4), 1994, pp. 10000290-10000290
Authors:
DURELLI L
BONGIOANNI MR
FERRI R
CAVALLO R
AIMO G
FERRERO B
RIVA A
BRADAC GB
BERGAMASCO B
BERGAMINI L
Citation: L. Durelli et al., INTERFERON (IFN)-ALPHA(2A) TREATMENT OF RELAPSING REMITTING (R/R) MULTIPLE-SCLEROSIS (MS) - DISEASE-ACTIVITY RESUMES AFTER STOPPING TREATMENT/, Neurology, 44(4), 1994, pp. 10000358-10000358
Authors:
DURELLI L
BONGIOANNI MR
CAVALLO R
FERRERO B
FERRI R
FERRIO MF
BRADAC GB
RIVA A
VAI S
GEUNA M
BERGAMINI L
BERGAMASCO B
Citation: L. Durelli et al., CHRONIC SYSTEMIC HIGH-DOSE RECOMBINANT INTERFERON ALFA-2A REDUCES EXACERBATION RATE, MRI SIGNS OF DISEASE-ACTIVITY, AND LYMPHOCYTE INTERFERON-GAMMA PRODUCTION IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Neurology, 44(3), 1994, pp. 406-413
Authors:
BONGIOANNI MR
FERRIO MF
FERRERO B
VAI S
GEUNA M
DURELLI L
Citation: Mr. Bongioanni et al., CHRONIC SYSTEMIC RECOMBINANT-ALPHA-2A-INTERFERON (R-ALPHA(2A)-IFN) INHIBITS LYMPHOCYTE GAMMA-IFN PRODUCTION IN MS, Neurology, 43(4), 1993, pp. 164-164
Authors:
FERRIO MF
DURELLI L
FERRI R
CAVALLO R
FERRERO B
MAGGI G
CASADIO C
BERGAMINI L
Citation: Mf. Ferrio et al., LYMPHOCYTE IMMUNOPHENOTYPES IN THYMUS AND PERIPHERAL-BLOOD (PB), ANTIACETYLCHOLINE RECEPTOR (ACHR) ANTIBODIES (AB) AND CLINICAL OUTCOME AFTER THYMECTOMY IN MG - A PROSPECTIVE LONG-TERM STUDY, Neurology, 43(4), 1993, pp. 165-166
Authors:
DURELLI L
CAVALLO R
FERRERO B
BONGIOANNI MR
DUTTO A
PECCHIO F
BERGAMASCO B
Citation: L. Durelli et al., DOES AN ACUTE INCREASE OF ANTIACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY (AB) TITER CONTRIBUTE TO CORTICOSTEROID (ST)-INDUCED WORSENING OF MG, Neurology, 43(4), 1993, pp. 165-165
Authors:
DURELLI L
FERRIO MF
URGESI A
POCCARDI G
FERRERO B
BERGAMINI L
Citation: L. Durelli et al., TOTAL-BODY IRRADIATION FOR MYASTHENIA-GRAVIS - A LONG-TERM FOLLOW-UP, Neurology, 43(11), 1993, pp. 2215-2221
Authors:
BAJETTA E
ZILEMBO N
DIBARTOLOMEO M
DILEO A
PILOTTI S
BOCHICCHIO AM
CASTELLANI R
BUZZONI R
CELIO L
DOGLIOTTI L
PINOTTI G
AITINI E
LABIANCA R
FORNASIERO A
RIVA P
SCHIEPPATI G
NELLI P
MARIANI L
ATTARD M
BARDUAGNI M
BELLU F
BUZZI F
DAPRILE M
DEMARINO E
EPIFANI C
FARINA G
FATTORI PP
FERRERO B
FOSSER V
IIRILLO A
LORUSSO V
MAIFREDI G
MEROZZI P
PASINI F
SARTI EL
SCANNI A
VERUSIO C
VILLA E
Citation: E. Bajetta et al., TREATMENT OF METASTATIC CARCINOIDS AND OTHER NEUROENDOCRINE TUMORS WITH RECOMBINANT INTERFERON-ALPHA-2A - A STUDY BY THE ITALIAN TRIALS IN MEDICAL ONCOLOGY GROUP, Cancer, 72(10), 1993, pp. 3099-3105
Risultati:
1-18
|